Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Study ID
- NCT06798532
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Neuroblastic Tumors
- Neuroblastoma
- Tumor, Solid
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Collection of data from the patient's medical file. — OTHERCollection of data from the patient's medical file.
Study Details
Neuroblastic tumors (NBTs) develop from neural crest cells that give rise to the sympathetic nervous system. They include neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. They represent approximately 10% of solid tumors in children under 15 years of age. In 15 to 20% of cases, NBTs are located in the thoracic region. These paravertebral tumors have an extracanal component and some also have an intraspinal component (dumbbell tumors) that can cause spinal cord compression. Surgery for these tumors also exposes the patient to neurological complications. In the thorax, the basi-thoracic location (T9-T12) may be particularly at risk due to the presence of the artery of Adamkiewicz (AKA), which supplies blood to the spinal cord; damage to this artery can result in spinal cord ischemia. To avoid this scenario, some teams recommend performing spinal cord arteriography to identify AKA. However, many centers do not perform arteriography and do not report more postoperative complications. Currently, there is no consensus on the indications for performing preoperative spinal arteriography in patients undergoing surgery for basi-thoracic NBT. This study evaluates the practice in France of preoperative arteriography to identify the AKA among patients undergoing surgery for basi-thoracic neuroblastic tumors and analyzes the incidence of postoperative neurological complications in these patients.
Key Dates
- Start date
- Oct 31, 2025
- Status verified
- Sep 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Pediatric patientsPatients undergoing surgery for a neuroblastic tumor (neuroblastoma, ganglioneuroblastoma) with basi-thoracic location between T8 and L1, with or without intraspinal component and treated in a pediatric surgery department in France between 2005 and 2024.
Primary Outcome Measure
Occurrence of neurological complications secondary to spinal cord ischemia [ Time Frame: 2005 to 2024 ]
Central Contacts
- Sabine MD, PhD Sarnacki0033144494194
- Hélène Morel0033171196346
Related Studies
- Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical OutcomeRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Prospective Comprehensive Molecular Analysis of Endocrine NeoplasmsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesRecruiting · National Cancer Institute (NCI) · Washington D.C., District of Columbia